A phase I investigator initiated inhalation safety trial of AB569 in healthy volunteers.

Trial Profile

A phase I investigator initiated inhalation safety trial of AB569 in healthy volunteers.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 27 Mar 2018

At a glance

  • Drugs Nitrite (Primary)
  • Indications Burkholderia cepacia infections; Pseudomonal infections; Staphylococcal infections
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 27 Mar 2018 According to an Arch Biopartners media release, the first patients were recruited and enrolled in the trial in February 2018. Dr. Ralph Panos is the lead investigator of the trial.
    • 13 Feb 2018 According to an Arch Biopartners media release, Cincinnati Veterans Affairs Medical Center (CVAMC) is now actively recruiting and enrolling healthy volunteers in this trial.
    • 13 Feb 2018 Status changed from planning to recruiting, according to an Arch Biopartners media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top